Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea

Detalles Bibliográficos
Autores principales: Kim, Kyuho, Choi, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369211/
https://www.ncbi.nlm.nih.gov/pubmed/34352987
http://dx.doi.org/10.4093/dmj.2021.0158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369211/
https://www.ncbi.nlm.nih.gov/pubmed/34352987
http://dx.doi.org/10.4093/dmj.2021.0158

Ejemplares similares